M. Ranke

发表

Segmental maternal UPD(7q) in Silver–Russell syndrome

T. Eggermann, N. Schoenherr, S. Jäger, 2008, Clinical genetics.

Growth hormone treatment of short children born small for gestational age or with Silver–Russell syndrome: results from KIGS (Kabi International Growth Study), including the first report on final height

M. Ranke, A. Lindberg, 1996, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Use of multiplex ligation‐dependent probe amplification increases the detection rate for 11p15 epigenetic alterations in Silver–Russell syndrome

T. Eggermann, N. Schoenherr, M. Ranke, 2007, Clinical genetics.

Growth hormone insensitivity syndromes: a preliminary report on changes in insulin‐like growth factors and their binding proteins during treatment with recombinant insulin‐like growth factor I

M. Ranke, K. Hall, W. Blum, 1993, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls

M. Ranke, W. Blum, P. Wilton, 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Adverse events during treatment with recombinant insulin‐like growth factor I in patients with growth hormone insensitivity

M. Ranke, P. Wilton, 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Classification of growth hormone insensitivity syndrome.

M. Ranke, L. Underwood, Z. Laron, 1993, The Journal of pediatrics.

Prediction of the growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia International Growth Study

M. Ranke, A. Lindberg, O. Guilbaud, 1993, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Is there an Auxological Basis for Growth‐Promoting Treatment with Human Growth Hormone in Short Children?

M. Ranke, M. Ranke, B. Blank, 1990, Acta paediatrica Scandinavica. Supplement.

Insulin‐Like Growth Factor Binding Proteins (IGFBPs) with Special Reference to IGFBPS

M. Ranke, M. Ranke, W. Blum, 1990 .

Final height in idiopathic growth hormone deficiency: the KIGS experience

M. Ranke, M. Ranke, P. Chatelain, 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Normal Progression of Testicular Size in Boys with Idiopathic Short Stature and Isolated Growth Hormone Deficiency Treated with Growth Hormone: Experience from the KIGS

M. Ranke, P. Chatelain, E. Reiter, 2002, Hormone Research in Paediatrics.

Short‐term increments of insulin‐like growth factor I (IGF‐I) and IGF‐binding protein‐3 predict the growth response to growth hormone (GH) therapy in GH‐sensitive children

M. Ranke, H. Wollmann, G. Binder, 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.

The diagnosis of growth hormone deficiency (GHD) in adults.

M. Ranke, M. Irie, B. Bengtsson, 1995, The Journal of clinical endocrinology and metabolism.

Predicting the response to recombinant human growth hormone in Turner syndrome: KIGS models

M. Ranke, P. Chatelain, D. Price, 1999, Acta paediatrica.

Growth Response in Prepubertal Children with Idiopathic Growth Hormone Deficiency during the First Year of Treatment with Human Growth Hormone. Analysis of the Kabi International Growth Study.

M. Ranke, M. Ranke, O. Guilbaud, 1990, Acta paediatrica Scandinavica. Supplement.

Clinical Spectrum of the Syndrome of Growth Hormone Insensitivity

M. Ranke, M. Preece, P. Chatelain, 1991, Acta paediatrica Scandinavica. Supplement.

Growth hormone insensitivity syndromes

M. Ranke, M. Savage, M. Ranke, 1995, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Malnutrition, zinc supplementation and catch‐up growth: changes in insulin‐like growth factor I, its binding proteins, bone formation and collagen turnover

M. Elmlinger, M. Ranke, M. Ranke, 2002, Clinical endocrinology.

Growth hormone treatment of idiopathic short stature: analysis of the database from KIGS, the Kabi Pharmacia International Growth Study

M. Ranke, M. Ranke, A. Lindberg, 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Growth Response in Prepubertal Children with Idiopathic Growth Hormone Deficiency During the First Two Years of Treatment with Human Growth Hormone. Analysis of the Kabi Pharmacia International Growth Study

M. Ranke, O. Guilbaud, M.B. RANKE, 1991, Acta paediatrica Scandinavica. Supplement.

Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells.

M. Elmlinger, M. Ranke, M. Ranke, 2004, Journal of molecular endocrinology.

Efficacy and Safety of Growth Hormone Treatment in Children with Prior Craniopharyngioma: An Analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996

M. Ranke, M. Ranke, P. Chatelain, 1998, Hormone Research in Paediatrics.

Late effects and quality of life

M. Ranke, F. Zintl, H. Gadner, 2001, Bone Marrow Transplantation.